戻る Agenda
Clinical Outcome Assessment for Clinical Trials: PROs, ClinROs, and ObsROs
Session Chair(s)
Melvyn Greberman
Public Health Resources, United States
This session will discuss the use of patient-reported outcomes (PROs), clinician-reported outcomes (ClinROs), and observer-reported outcomes (ObsROs) to assess treatment benefits in clinical trials, and collaborative ventures that support scientific, regulatory, and clinical applications in the US and other countries.
This session has been developed by the Clinical Research Community.
Learning Objective : Describe the differences between PRO, ClinRO, and ObsRO data; Describe public-private sector collaborations that support the development and use of computer-based systems in clinical trials.
Speaker(s)
Current Challenges for Clinical Research in Our Rapidly Changing Health System
J. Michael Fitzmaurice, PHD, FACMI
Agency for Healthcare Research and Quality (AHRQ), United States
Senior Science Advisor for Information Technology, Office of the Director
The Challenge of Collecting Reliable Patient Outcome Data
Stanley A. Edlavitch, PHD, MA
University of Missouri Kansas City, United States
Professor, Epidemiology, School of Medicine; Center for Behavioral Medicine
Clinical Outcome Assessments: Use in Clinical Trials to Demonstrate Treatment Benefit
Elektra Papadopoulos, MD, MPH
AbbVie, United States
Director, Patient Experience Data and Strategy